News
- 2025/11/19
- Registration of a Patent related to Noile-Immune's Developed Technology Completed in Japan
- 2025/11/07
- Noile-Immune announces that Keishi Adachi, D.V.M., Ph.D., Associate Professor of Yamaguchi University which is conducting joint research with Noile-Immune, presented the data on allogeneic CAR-T cell therapy with PRIME technology in the session “Frontiers in Tumor Immunology” at the 38th Annual Meeting of the Japanese Society for Biological Therapy (November 6-7, 2025, in Yamaguchi City, Yamaguchi Prefecture).
- Meeting: 38th Annual Meeting of the Japanese Society for Biological Therapy (November 6-7, 2025, in Yamaguchi City, Yamaguchi Prefecture)
- Session: Frontiers in Tumor Immunology
- Presentation title: Development of Next-generation CAR-T Cell Therapy for Solid Tumors based on Epitope Spreading
- Presenter: Keishi Adachi, D.V.M., Ph.D., Associate Professor (Department Immunology, Yamaguchi University Graduate School of Medicine / Research Institute for Cell Design Medical Science, Yamaguchi University)
- 2025/10/01
- Noile-Immune’s President & CEO, Koji Tamada, MD, Ph.D., will give a seminar presentation at BioJapan2025 (from Wednesday, October 8 to Friday, October 10 at PACIFICO Yokohama).
- ・Date and time: Wednesday, October 8, 2025, 14:00–15:00
・Venue： Annex Hall F202, PACIFICO Yokohama
・Seminar: Sponsor Seminar; Takara Bio, Endeavor and future perspective in research and development of novel CAR-T technologies
・Presentation title: Endeavor and future perspective in research and development of novel CAR-T technologies
・Presenter: Koji Tamada MD, Ph.D. (Professor at Graduate School of Medicine / Director at Research Institute for Cell Design Medical Science, Yamaguchi University)
Information on the seminars is here. (BioJapan2025 site)
- 2025/09/26
- Notice of Exhibition at BioJapan 2025
- Noile-Immune will exhibit at BioJapan 2025, which will be held at Pacifico Yokohama from October 8 (Wed) to October 10 (Fri), 2025. At Yamaguchi Prefectural Industrial Technology Institute exhibition booth (Booth No.: B-42), Noile-Immune will introduce its proprietary PRIME technology, an innovative approach to enhance the therapeutic effects of immune cell therapy.
Official site (English):https://jcd-expo.jp/en/about.html
- 2025/09/19
- Noile-Immune’s President & CEO, Koji Tamada, MD, Ph.D. (Professor at Yamaguchi University Graduate School of Medicine), will give a lecture at “The 84th Annual Meeting of the Japanese Cancer Association (from Thursday, September 25 to Saturday, September 27 in Kanazawa).
- ・Date and time: Thursday, September 25, 2025, 12:50–15:20
・Venue： Room 1; Ishikawa Ongakudo, 2nd Floor “Concert Hall”
・Session: Hajime Okamoto Memorial Symposium
・Session Title: SS5 Exit-Oriented Drug Discovery Technology from Academia
・Lecture Title: SS5-3 Clinical development of next-generation CAR-T technologies originated from academic institutions
・Speaker: Koji Tamada MD, Ph.D. (Professor at Yamaguchi University Graduate School of Medicine)
Information on the 84th Annual Meeting of the Japanese Cancer Association is here.